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Abstract:  Economic uncertainty surrounds the distribution of Raboral V-RG7 as an oral rabies 
vaccine (ORV) bait for the containment or elimination of raccoon-variant rabies in the United States. 
This paper describes a costs-savings model of ORV.  It also describes Excel XP7 code that was 
prepared to compute potential net savings (NS) and benefit-cost ratios (BCRs) associated with 
Raboral V-RG7 bait distributions.  Currently, baits and bait distributions are relatively expensive; 
individual baits are produced at a cost of $1.27 for federal use and typically dispensed at >75 
baits/km2.  Distribution is estimated at $8.62/km2, $15.80/km2, and $33.30/km2 for fixed-winged 
(FW), ground (Gnd), and rotary-winged (RW) applications, respectively.  Although many 
assumptions are required, iterative runs of the code allow plotting NS and BCR response surfaces for 
diverse scenarios based on 6 ORV variables:  area (km2), bait-price (US$/vaccine bait), bait-density 
(#/km2), application frequency (n), mode-of-delivery [$US for % fixed-winged (FW), % rotary-
winged (RW), and % ground-dispensed (Gnd)], and effectiveness (% seropositive titer conversion).  
Using a raccoon-rabies-epizootic-containment scenario for parts of Pennsylvania and a modest 
epizootic cost estimate of $40 million, the greatest NS ($6.4 to 38.4 million) and BCR (2.85 to 
25.76) indices occurred for a one-time bait distribution involving FW aircraft over a fourth of the 
state with a $0.90/bait price.  As expected, greater reliance on the more expensive RW and Gnd 
modes of bait distribution compared to FW aircraft, coupled with higher bait prices and higher bait 
densities, decreased NS and BCR indices.  The utility of the approach to economic forecasting and 
decision making of ORV effects are discussed. 
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Proceedings of the 10th Wildlife Damage 
Management Conference. (K.A. Fagerstone, 
G.W. Witmer, Eds). 2003 
 
 
INTRODUCTION 
Oral wildlife vaccines have been 
effective in limiting or eliminating coyote 
(Canis latrans) and red fox (Vulpes vulpes) 
transmitted rabies in areas  of North America  
 
 
(Farneyhough et al. 1998; MacInnes et al. 
2001).  Currently, raccoon variant rabies is 
enzootic, or likely to become enzootic, in 19 
Eastern states (i.e., Alabama, Connecticut, 
Delaware, Florida, Georgia, Maine, Maryland, 
Massachusetts, New Hampshire, New Jersey, 
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New York, North Carolina, Pennsylvania, 
Rhode Island, South Carolina, Tennessee, 
Vermont, Virginia, and West Virginia) and 
the District of Columbia (CDC 2001). Fish-
meal polymer baits exist for effectively 
delivering oral vaccines to raccoons (Olson et 
al. 2000); These are Raboral V-RG7 baits 
(Merial Limited, Athens, Georgia, USA).  An 
ORV program has been initiated to vaccinate 
wild raccoons along the Appalachian Ridge to 
stop the westward spread of this disease 
(Foroutan et al. 2002, Slate et al. 2002, USDA 
2001). 
Economic uncertainty surrounds the 
use of these baits.  This is due in part to the 
difficulty in determining regional costs of the 
disease and in assessing potential savings 
likely to result from an ORV program.  
Although some data have been published 
about post-exposure human prophylaxis (PEP) 
and bait-distribution costs (see Foroutan et al. 
2002, Kemere et al. 2002, Kreindel et al. 
1998, Meltzer and Rupprecht 1998, Uaaa et 
al. 1992), these studies lack systematic 
projections of the relative costs and savings 
likely with ORV. 
Recently, Sterner (2002), Sterner and 
Lorimer (2001), and Sterner and Tope (2002) 
described an a priori approach to examining 
the potential benefits and costs of wildlife-
damage-management activities.  Spreadsheet 
software (Lotus7 1-2-37, 9.5 software, Lotus 
Development, Cambridge, MA) was used to 
compute iterative net savings (NSs) and 
benefit-cost ratios (BCRs) linked with the use 
of several wildlife management products (e.g., 
a rodenticide for vole control in alfalfa, a 
commercial repellent for nuisance goose 
management at golf courses).  Fixed scenarios 
were used to illustrate the possible losses and 
prevention of losses likely from the use of 
these products.  Multiple runs of the 
programs, with 1-factor-changed-at-a-time 
(e.g., product price, application rate, 
persistence, area treated, amount of loss 
expected), allowed plotting numerous NS and 
BCR outputs for a range of inputsBthe 
response surfaces of these indices.  The 
approach afforded useful simulations of 
potential benefits and costs linked with the 
products. 
Here, we present a cost-savings model 
for using ORV to contain raccoon-variant 
rabies.  We then describe Excel XP7 code 
(Microsoft7 Corp., Richmond, Washington, 
USA) that was prepared to estimate NS and 
BCR indices associated with key factors 
involved in Raboral V-RG7 bait distribution; 
a hypothetical ORV scenario is used to 
illustrate use of the code. 
 
COST-SAVINGS MODEL 
Our model attributes the impact of 
animal rabies in the U. S. economy to diverse 
veterinary, medical, legal, and insurance 
costs. The potential saving any of these costs 
is viewed as the benefit of ORV. 
 
Nature of Costs-Savings 
Economists identify 3 categories of 
costs and benefits:  direct, indirect, and 
induced (see Field 2001).  Direct costs involve 
actual monetary expenses attributable to 
occurrence of rabies (e.g., pet vaccination 
biologics, replacement price of a companion 
animal, ORV bait, rabid animal quarantine, 
pre- and post-exposure medical prophylaxis, 
life insurance claim).  The term indirect refers 
to those tangential costs or savings that are 
rabies-related expenses but which are 
incidental to direct costs (e.g., lost work by 
patients due to side effects of prophylaxis, 
travel to medical facilities).  Induced costs 
also refer to a class of tangential costs or 
savings that are due strictly to implementation 
of ORV (e.g., labor costs to trap raccoons for 
rabies surveillance, serum tests on raccoons to 
monitor vaccine effectiveness).  
 
Nature of Rabies and ORV 
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Multiple variants of the rabies virus 
occur in the U. S.:  bat, canine coyote, arctic 
fox, red fox, raccoon, and skunk (Childs 
2002).  These variants currently occupy 
prescribed geographical regions, but variants 
ascribed to different mammals occur 
simultaneously (overlap) in certain regions 
(Childs 2002).  Any mammal can contract 
rabies from a bite by an animal having these 
variants; thus, it=s possible to have a rabid 
raccoon occur in California even though the 
raccoon variant virus has not been identified 
there (e.g., contract rabies from a bat).  While 
ORV baits exist for coyote, fox, and raccoons, 
oral vaccines for bat or skunk variant rabies 
have yet to be developed (Johnston and 
Tinline 2002). 
 
Equations 
The following equations define our 
model: 
 
C = [CAV + LV + CAR + LR + Q + 
PreEP + PEP + PH + HD], 
 
where C is the additive cost of a raccoon 
variant rabies epizootic ($US).  If ORV is 
effective, these costs become potential savings 
(S).  Epizootic C is attributed to 9 main 
variables:   
CAVBCompanion animal vaccinations  
(n Α $US/vaccination),  
LVB livestock vaccinations  
(n Α $US/vaccination),  
CARBcompanion animal replacements  
(n Α $US/animal for rabies-caused 
deaths),  
LRBlivestock replacements  
(n Α $US/head for rabies-caused 
deaths),  
QBquarantine of suspected rabid animals  
(n Α $US/event),  
PreEPBhuman pre-exposure-prophylaxis 
(n Α $US/vaccination),  
PEPBhuman post-exposure-prophylaxis  
(n Α $US/treatments),  
PHBpublic health charges  
(n Α $US/event for case investigations 
and laboratory tests),  
HDBinsured human death claims (n Α 
$/death). [Note.BTo date, one human death 
has been attributed to raccoon rabies.] 
Potential net savings (NS) afforded by 
raccoon variant ORV are viewed as C less the 
ORV costs and any accident-related charges 
(ACC): 
 
NS = (C Α E) - (ORV + ACC). 
 
where NS is total net savings, C  is defined 
above, E is the likely effectiveness benefit 
(sero-positive conversion), ORV is the cost of 
the baiting program and is dependent upon:  
area (km2), bait cost ($US/bait), bait density 
(baits/km2), mode-of-bait distribution [($US 
fixed-wing /rotary-wing /ground 
(%FW/%RW/%Gnd)], number of baitings (n), 
and ACC is baiting-related accidents/injuries 
(n Α $US/medical + $US/liability settlement). 
[Note.BBait equipment is considered a pro-
rated $US charge embedded with mode-of-
bait distribution; currently such equipment 
sells for about $3,500/unit and is 
computerized to dispense baits at prescribed 
rates on GIS-based azimuths; C. MacInnes, 
personal communication, 2003).  Obviously, 
effectiveness is difficult to derive; it assumes 
that returns on invested ORV monies are 
related to the proportion of raccoons 
successfully vaccinated as well as overall 
suppression of the disease and curtailment of 
future costs.  These are not necessarily 
equivalent or directly related; it is unknown 
what portion of a population of raccoons need 
to be vaccinated within an area to successfully 
stop transmission or eliminate the disease.  
Still, for current purposes, we have elected to 
model this factor based upon the simple 
percentage of raccoons hypothetically 
vaccinated (i.e., 25, 50, 75, or 100%) --
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hypothetical effectiveness of preventing 
rabies-incurred costs.  Additionally, ACC is 
considered to be zero ($0.00).  To date, only 1 
accidental dosing with the Raboral V-RG7 
bait has occurred; an Ohio woman was dosed 
while trying to retrieve a bait from her dog.  
This incident was resolved in court; medical 
assistance was waived by the plaintiff and no 
liability was determined (R. Hale, personal 
communication, 2003). 
Finally, a BCR is derived using the 
potential savings (S) in costs of the epizootic, 
or the expected C: 
 
BCR = (C Α E) ) (ORV + ACC), 
 
where C, E, ORV, and ACC are defined as 
above.  This ratio reflects potential future 
savings in raccoon epizootic expenses due to 
Raboral V-RG7 bait distribution.  It is a 
relative value, rendering area (km2) irrelevant. 
A ratio of 1.0 refers to equality of ORV 
expenses and potential S; values <1.0 or >1.0 
indicate that benefits are likely to be smaller 
or larger than ORV outlays, respectively. 
 
ESTIMATING ECONOMIC EFFECTS 
OF ORV 
Excel XP7 code was prepared to 
compute and graph BCR and NS indices 
associated with ORV bait distributions.  As 
implied in the model, 6 parameters are viewed 
to determine the potential costs of Raboral V-
RG7 bait distributions:  (1) area of bait 
application (km2), (2) bait price ($/bait), (3) 
bait density (baits/km2), (4) bait application 
frequency (n), (5) mode of bait distribution 
(km2 FW, RW, and Gnd), and (6) 
effectiveness (% sero-positive conversion of 
wild raccoons).  Of course, the probable cost 
(C) of the epizootic (or potential S) must be 
input.  Induced costs of surveillance and 
testing raccoons in ORV areas were not 
programmed.  Iterative, 1-variable-changed-
at-a-time runs of this code allowed plots and 
descriptions of the economic response 
surfaces that would be attributed to 
manipulations of specific variables substituted 
for the parameters. 
 
Excel XP7 Code 
Figure 1 presents the Excel XP7 
output of potential NS and BCR indices.  
Detailed code for computing several cells of 
the spreadsheet is given in the caption; 
formulas for remaining cells of the matrix are 
readily derived by substitution. 
As shown, input descriptors are listed 
in Cells A2-A7 of the sheet; these request 
information for area (km2), FW (%), RW (%), 
Gnd (%) application, rabies cost ($US), and 
number of baitings (n).  Actual inputs for 
these variables are entered in Cells B2-B7, 
respectively.  Formulas for computing BCRs 
involving 5 designated bait prices [i.e., $0.90, 
$1.10, $1.30, $1.50, and $1.70; Column D 
(Cells D10-13, D15-18, D20-23, D25-28, and 
D30-33, respectively)] combined with each of 
4 bait densities [i.e., 50, 75, 100, and 125 
baits/km2; Column E (Cells E10-13, E15-18, 
E20-23, E25-28, and E30-33, respectively)] 
and each of 4 sero-positive effectiveness 
variables [i.e., 25% in Column F (Cells F10-
13, F15-18, F20-23, F25-28, and F30-33, 
respectively); 50% in Column G (Cells G10-
13, G15-18, G20-23, G25-28, and G30-33, 
respectively); 75% in Column H (Cells H0-
13, H15-18, H20-23, H25-28, and H30-33, 
respectively); and 100% in Column I (Cells 
I10-13, I15-18, I20-23, I25-28, and I30-33, 
respectively)] are programmed into the 
intersecting cells of the code.  A similar 
matrix of NS values for these same inputs for 
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Figure 1.  Schematic view of Excel XP7 output used to perform net savings and benefit-cost ratio estimates.  Selected cell formulas are:  
F10=($B$6*$F$9)/((($D$10*E10*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7), 
I33=($B$6*$I$9)/((($D$30*E33*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7), 
M10=($B$6*$M$9)-((($K$10*L10*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7), 
P3 =($B$6*$P$9)-((($D$30*L33*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7). 
A      B         C*   D      E        F         G        H        I        J     K         L   M                 N                O                 P     
  1                  
Area sq. km 29021 2              
%FW 100% 3              
%RW 0% 4              
%ATV 0% 5              
Epidemic cost $40,000,000 6 Benefit-Cost  Ratios     Net Savings     
Baitings 1 7              
  8 Cost/ 
Bait 
Bait 
Density 
Sero+ Conversion Rates  Cost/ 
Bait 
Bait 
Density
Sero+ Conversion Rates  
  9   25% 50% 75% 100%    25% 50% 75% 100% 
  10 $0.90  50 6.44 12.88 19.32 25.76  $0.90  50 $8,447,377 $18,447,377 $28,447,377 $38,447,377 
  11  75 4.53 9.07 13.60 18.14   75 $7,794,404 $17,794,404 $27,794,404 $37,794,404 
  12  100 3.50 7.00 10.49 13.99   100 $7,141,432 $17,141,432 $27,141,432 $37,141,432 
  13  125 2.85 5.70 8.54 11.39   125 $6,488,459 $16,488,459 $26,488,459 $36,488,459 
  14              
  15 $1.10  50 5.43 10.85 16.28 21.71  $1.10  50 $8,157,167 $18,157,167 $28,157,167 $38,157,167 
  16  75 3.79 7.57 11.36 15.15   75 $7,359,089 $17,359,089 $27,359,089 $37,359,089 
  17  100 2.91 5.82 8.72 11.63   100 $6,561,012 $16,561,012 $26,561,012 $36,561,012 
  18  125 2.36 4.72 7.08 9.44   125 $5,762,934 $15,762,934 $25,762,934 $35,762,934 
  19              
  20 
9 
 $1.30  
9 
       50    
       9 
     $1.30 
9 
50 
  9 
    
  24              
  25 
 
 $1.50  
9 
       50    
       9 
     $1.50 
9 
50 
  9 
    
  29              
  30 $1.70 50 3.69 7.37 11.06 14.74   50 $7,286,537 $17,286,537 $27,286,537 $37,286,537 
  31  75 2.53 5.07 7.60 10.13   75 $6,053,144 $16,053,144 $26,053,144 $36,053,144 
  32  100 1.93 3.86 5.79 7.72   100 $4,819,752 $14,558,563 $24,819,752 $34,819,752 
  33  125 1.56 3.12 4.68 6.24   125 $3,586,359 $13,586,359 $23,586,359 $33,586,359 
* Denotes row number; this column is blank in code.
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bait prices, bait densities, and sero-positive 
effectiveness variables occurs in Column K  
[i.e., $0.90, $1.10, $1.30, $1.50, and $1.70; 
(Cells K10-13, K15-18, K20-23, K25-28, and 
K30-33, respectively), Column L [i.e., 50, 75, 
100, and 125 baits/km2; Cells L10-13, L15-18, 
L20-23, L25-28, and L30-33, respectively) 
and sero-positive effectiveness variables in 
Columns M (i.e., 25% in Cells M10-13, M15-
18, M20-23, M25-28, and M30-33, 
respectively), N (i.e., 50% in Cells N10-13, 
N15-18, N20-23, N25-28, and N30-33, 
respectively), O (i.e., 75% in Cells O10-13, 
O15-18, O20-23, O25-28, and O30-33, 
respectively), and P (i.e., 100% in Cells P10-
13, P15-18, P20-23, P25-28, and P30-33, 
respectively), respectively.  The actual prices 
for mode of bait distribution (i.e., FW 
$8.62/km2, RW $33.30/km2, and Gnd 
$15.80/km2) are coded into the formulas; 
these costs were derived from published 
literature (see Kemere et al. 2002; Foroutan et 
al. 2002).  Expenses for machines to dispense 
baits were assumed to be pro-rated into the 
mode-of-bait distribution costs (i.e., cost of 
FW, RW, Gnd; $US/km2). 
 Table 1 provides a mathematical 
example of a specific calculation for cost, net 
saving, and benefit cost ratio. 
 
 
Table 1.  Mathematical Example 
 Area = 1,000 km2 
 FW 40% ($8.62/km2), RW 20% ($33.30/km2), Gnd 40% ($15.80/km2) 
 Epizootic cost = $1,000,000.00 
 Number of Baitings = 3 repeats 
 Cost/bait = $0.90 
 Bait Density = 50/km2 
 Sero-positive conversion among raccoons = 0.50 
  
C  =  (Rabies-incurred Cost) 
  =  $1,000,000.00 
NS   =  [(Total Rabies Cost Α Sero+ Effectiveness) - (ACC + ORV)] 
  =  [($1,000,000 Α 0.50) - {[$0.00 accidents] + {[($0.90 bait price Α 50 baits/km2 Α 
1000 km2) + (1000 km2 (0.40 FWΑ $8.62) + 1000 km2 (0.20 RW Α $33.30) + 1000 
km2 (0.40 Gnd Α $15.80) Α 3 bait distributions]  
  = [($500,000) - ($0.00 + [($45,000) + ($7000 + $6660 + $6320)] Α 3} 
  = [($500,000) - ($194,940)] 
  = $305,060 
BCR  = [(Total Rabies Cost Α Sero+ Effectiveness) )  (ACC + ORV)] 
  = [($500,000) ) ($0.00 + $194,060)] 
  = +2.56 (i.e., savings in costs of raccoon rabies epizootic are more than double the 
expenses of implementing ORV with half of the raccoon population vaccinated).
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A Scenario  
An attempt is made to prevent a raccoon 
rabies outbreak in parts of Pennsylvania from 
spreading throughout the state.  A focal point of 
rabid animals has been identified in several 
clustered counties.  Raboral V-RG7 baits are to 
be applied over a fourth of the state radiating out 
from the cluster to prevent the epizootic from 
reaching the remaining counties. 
Raccoon Rabies Potential Savings.BA 
key input needed to compute BCRs and NSs is 
the expected costs incurred due to the 
epizooticBthe potential savings from ORV.  Our 
code requires input based on C ($US).  For 
current calculations, we have used a single 
valueB$40 million.  While this is a hypothetical 
C or S, it can be justified based upon empirical 
data. 
Increased PEP and pet vaccinations are 
the major economic components of any rabies 
epizootic (Meltzer 1996).  Kriendel et al. (1998) 
surveyed the costs of medical PEPs during a 
1995 epizootic of raccoon rabies in 
Massachusetts, and reported that the rate of 
medical use for Human Rabies Immune Globulin 
(HRIG) went from a baseline of 17/100,000 to 
45/100,000 citizens between 1991 and 1995.  The 
cost of the HRIG (biologic) alone varied between 
$632 and $3,435 (median value of $1,646), but 
when physician and hospital emergency-room 
charges were added, the direct per-patient cost 
ranged from a low of $1,038 to a high of $4,447 
(i.e., median PEP of $2,376).  Using area and 
population data for Pennsylvania (Rand McNally 
2002), converting this change in PEP incidence 
to 12,281,074 population for Pennsylvania yields 
an increase of 3,439 PEPs (17/100,000 vs 
45/100,000 or a shift of 28:100,000) and 
expected median-based PEP costs of 
$8,171,064/year.  Assuming that a raccoon rabies 
epizootic lasts 2 years (Meltzer 1996), direct PEP 
expenses for Pennsylvania would exceed $16 
million.  Add to this other direct costs for 
increased pet vaccinations (e.g., $5 million/year 
or $10 million for the epizootic), increased PH 
and Q expenses (e.g., $5 million/year or $10 
million for the epizootic), not to mention indirect 
costs such as lost wages, travel expenses, and 
child care expenses borne by patients (e.g., $2 
million/year or $4 million for the epizootic), and 
a total statewide cost of $40 million is easily 
justified. 
 
 
 
Table 2.  Input variables used for Raboral V-GR7 scenario projections.  
Variable Number of Levels Inputs 
Area baited (km2) 1 29,021a 
Bait price ($US/bait) 5 0.90, 1.10, 1.30, 1.50, 1.70 
Bait density (n/km2) 4 50, 75, 100, 125 
Number of baitings (n) 2 1, 3 
Rabies epizootic costs/savings ($US) 1 40,000,000 
Mode of application (% of km2)c 6 FW, RW, Gnd 
     FW  = $  8.62/km2 
     RW  = $33.30/km2 
     Gnd  = $15.80/km2 
 100,     0,     0 
    0, 100,     0 
    0,     0, 100 
  50,    50,    0 
  50,      0,  50 
    0,    50,  50 
Effectiveness (Sero+ %) 4 25, 50, 75, 100 
a One-fourth the area of PA. 
bNote.-- Bait-drop equipment included with lease rate for aircraft; FW cost from Kamere et al. (2002), RW and Gnd 
cost from Foroutan et al. (2002). 
c Although 161,700 combinations of the Amode@ settings are possible, we present data for only 6 combinations of 
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these variables.    
 
ORV Inputs.B  As mentioned, five bait 
price, four bait density, and four seropositive 
effectiveness variables are pre-coded into the 
analysis (Table 2).  A single input was used for 
the area baited (29,021 km2B1/4 the state of PA) 
and for the potential cost savings with ORV ($40 
million).  Dual inputs were used for the required 
number of baitings needed to suppress the 
outbreak (1 and 3).  Six mode-of-bait distribution 
combinations were used (RWB100%, 
GndB100%, FWB100%, RW-GndB50% each, 
RW-FWB50% each, and FW-GndB50% each). 
 
Data Analysis 
Each iteration of the code (mode-of-bait 
distribution) produced 80 NS and 80 BCR 
estimates (see Figure 1); thus, the six iterative 
runs yielded a total of 960 separate NS and BCR 
indices.  These were plotted to show the three-
dimensional response surface effects associated 
with the ORV variables. 
 
RESULTS AND DISCUSSION 
 
Scenario 
For a single baiting involving complete 
bait distributions via single modes of delivery 
(i.e.,  RW, Gnd, or FW), NS values ranged from 
2,866,638 to 38,447,377 (Figure 2a) and BCR 
values ranged from 1.40 to 25.76 (Figure 2b), 
respectively.  The need for 3 repeat baitings to 
suppress the epizootic via these sole modes of 
delivery yielded NSs between -$11,400,085 and 
+$35,342,130 (Figure 3a) and BCRs between 
0.47 and 8.59 (Figure 3b), respectively.  The 
greatest NS ($3.5 to 38.4 million) and BCR (1.56 
to 25.76) estimates occurred for a one-time bait 
distribution involving FW aircraft for the entire 
area. 
Lower bait prices ($0.90 to $1.70), lesser 
bait densities (50/km2 to 125/km2), fewer bait 
applications (1 vs. 3), and greater use of the 
cheaper FW mode of bait distribution yielded 
greater NS and higher BCR indices.  Regarding 
the iterative runs involving mode-of-bait 
distribution, increasingly positive NS and BCR 
indices occurred as the mode involved less RW 
or Gnd coverage relative to FW aircraft (i.e., RW 
< Gnd also yielded transitivity).  This same effect 
of inversely higher NS and BCR values was also 
observed for the dual modes of distributions (i.e., 
RW-Gnd, RW-FW, and FW-Gnd yielded lower 
NS and BCR values, respectively). 
These results readily show how economic 
impacts are dependent upon the relative price 
structure involved in ORV.  Bait price, bait 
density, mode of distribution, and repeated 
baiting interact to determine current ORV cost 
effectiveness.  At present, production of Raboral 
V-RG7 baits are labor intensive and involve 
individual preparation.  Sale to federal sources 
(United States Department of Agriculture 2001) 
is set at $1.27/baitBa price associated with BCRs 
>3.0 for all RW, Gnd, and FW bait distributions 
involving a single application.  The required 
density of baits needed to successfully vaccinate 
a sufficient segment of a raccoon population so 
as to create a rabies-free zone (Abarrier@) or to 
Aeliminate@ the disease is unknown.  This 
question is receiving intense research interest 
(see Kemere et al. 2002, Slate et al. 2002).  All of 
our computer runs involving #125 baits/km2 
produced >2.0 BCRs at bait prices <$1.30. 
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Figure 2.  A 3-dimensional graph of the response surface for (a) potential net savings and (b) 
potential benefit-cost ratios showing the effects of 1 and 3 repeated baitings with 100% RW, Gnd, 
and FW mode-of-bait distributions over 29,021 km2. 
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Figure 3.  A 3-dimensional graph of the response surface for (a) potential net savings and (b) 
potential benefit-cost ratios showing the effects of 1 and 3 repeated baitings with 50-50% RW-Gnd, 
RW-FW, and FW-Gnd mode-of-bait distributions over 29,021 km2. 
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Approach 
Our scenario results demonstrate the 
utility of using spreadsheet projections to 
evaluate potential economic impacts of Raboral 
V-RG7 bait distributions for containing or 
eliminating raccoon variant rabies in the Eastern 
U. S.  Despite numerous assumptions, we 
contend that our iterative projections of NS and 
BCR indices reduce the economic uncertainty 
associated with ORV.  The approach affords a 
quick, relatively inexpensive tool for modeling 
diverse ORV scenarios. The graphical and 
tabular displays of a range of NS and BCR 
indices for variables involved in ORV afford 
decision heuristics to be set up that ensure 
improved applications of the technology (e.g., 
keeping RW- and Gnd-based bait distributions to 
<30% of the total area, limit bait densities to 
<75/km2).  This approach shows how bait price, 
bait density, bait frequency, and bait 
effectiveness relate to overall cost effectiveness 
of ORV. 
A major implication of our scenario 
analysis is that more accurate estimates of the 
total costs which raccoon variant rabies exert on 
the U. S. economy are sorely needed.  These 
costs are critical to any determination of potential 
ORV benefits.  Also, realistic economic 
approaches to determining the pay-back scheme 
for wide-area ORV strategies need to be 
identified.  Empirical studies of not only direct, 
but indirect and induced costs/savings, associated 
with raccoon variant ORV will offer more 
precision for future analyses; whereas, pro-rated, 
multi-year benefits from ORV may more 
accurately characterize these returns on 
investments (Meltzer 1996).  While our use of a 
two-year, $40 million cost-savings value for a 
Pennsylvania focal outbreak was intentionally 
conservative, this scenario is a simple Asnap-
shot@ of how ORV benefits may impact future 
economies.  Still, even this showed that 1 or 3 
bait distributions over one-fourth of the state 
could yield significant savings and multiple 
returns on expenses assuming a specific bait 
price, density, and mode of distribution. 
Kemere et al. (2002) modeled the 
economic benefits of creating a hypothetical zone 
of vaccinated raccoons as a Abarrier@ to the 
westward spread of the disease using Raboral V-
RG7 (Merial Limited, Athens, Georgia, USA) 
baits.  The zone was viewed to encompass 
102,605 km2 and parallel areas along western 
parts of the Appalachian Ridge. A benefit-cost 
approach was used that assumed a 20-year period 
for creation and maintenance of the barrier.  
Estimates of diverse surveillance, medical, 
veterinary, and evaluation costs were compared 
to estimates of bait-application costs under four 
models, with potential savings tied to reduced 
need for these outlays west of the barrier.  Four 
models specified either a 40.2 (Models A and B) 
or a 127.1 (Models C and D) km/yr spread of 
raccoon variant rabies with or without the 
potential costs for epizootic-induced veterinary 
prophylaxis of domestic animals, respectively.  
Under these scenarios, program costs totaled 
$95.7 million; whereas, net benefits (discounted 
at 7%/yr) ranged between $48 and $496 million, 
depending upon whether bait applications 
continued unchanged or were scaled back (larger 
net benefits) after initial set up of the zone.  
Sensitivity analyses yielded mean (SD) net 
benefits of 202 (4.10), 109 (4.11), 496 (4.07, and 
313 (4.07) for Models A, B, C, and D, 
respectively. 
 
CONCLUSIONS 
Using a raccoon rabies epizootic 
suppression scenario for parts of Pennsylvania 
and a modest epizootic cost estimate of $40 
million, ORV was projected to yield NS values 
>2.8 million and BCR values >1.4, respectively. 
If numerous assumptions are made, Excel7 XP 
software can be used to make projections of NS 
and BCR associated with ORV.  Using the code 
we have generated, graphical and tabular displays 
of the response surfaces for key variables and 
numerous scenarios can be performed quickly. 
The approach offers a useful analytical tool for 
identification of critical cost thresholds for the 
myriad of cost factors that affect ORV.  The 
potential for simple heuristics to be devised that 
govern profitable/non-profitable applications of 
ORV should be a future asset. 
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